Multi District Litigation Assigned To Yaz Due To The Side Effects

According to the recent decisions by Judicial Panels on the Multi District Litigation’s, the US District Courts for all the Southern Districts of Illinois would be overseeing and hearing all of the drugs defect cases that would be brought to the federal courts involving the Yasmin,Yaz along with the other birth control drugs, that would be using drospirenone as their key ingredient. The cases, Multi District Litigation No. 2100, reflected state to state allegations that had been by the women that had been using these prescription birth controls that would be liable for the wrongful marketing along with the sales practices that would be resulting in the products liability.

Transferee Judge Herndon from Southern Illinois would be overseeing all of the federal litigation’s that would be involving the claims that would be against the Yaz and all the other related drugs to this type of case. The decisions to turn MDL’s over to Southern Illinois judges had been announced back on October 1st, only about 7 days after their initial hearing had become a MDL. This would be very significant when it would show the urgency of developing the clear determination in these causes of the injuries and the deaths, as well as these judicial imposed responsibilities of Bayer along with the other manufacturing companies that make these drugs.

The drugs Ocella, Yasmin and Yaz, along with all the other related contraceptives that have been linked right to the variety of the side effects, from the very mild cases that would consist of the headaches along with the vomiting all the way to the more serious side effects of the blood clots, heart attacks and strokes. Originally this had been just prescribed for the use as being the birth control, mild acne and premenstrual pains, these drugs would be containing the drospirenone which would be causing the increases of the potassium and the estrogen in ones bloodstream, and the factors would be contributing to the complications that would be leading to the pulmonary embolisms, the deep vein thrombosis, along with the strokes and the heart attacks.

After a week of their decision on accepting all the cases against the Bayer company and the other related manufacturers as the MDL-2100, Bayer had admitted that about 129 lawsuits have been files against them that had been involving the Yasmin and Yaz. As these cases would now be crossing only the desk of Judge Herndon, it would be estimated that about thousands of these cases would be involved with this MDL that will still be coming in the next months.

On average, the Bayer Company would be earning about $1.8 billion for their sales of the Yazmin drug, and while these cases along with the allegations would be continuing to be piling up, these prescription contraceptives are still readily available along with still being given to women all across the US.